Latest period
$524.00M
YoY change
+24.0%
5Y CAGR
+4.7%
Peak year (1999)
$1.10B
Cumulative CapEx
$8.42B
CapEx history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $527.00M
CapEx growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +24.0%
CapEx history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $527.00M | +24.0% | +$102.00M | ||
| 2024 | $425.00M | +4.2% | +$17.00M | ||
| 2023 | $408.00M | +1.0% | +$4.00M | ||
| 2022 | $404.00M | +0.2% | +$1.00M | ||
| 2021 | $403.00M | -3.6% | −$15.00M | ||
| 2020 | $418.00M | +4.5% | +$18.00M | ||
| 2019 | $400.00M | +4.4% | +$17.00M | ||
| 2018 | $383.00M | +52.0% | +$131.00M | ||
| 2017 | $252.00M | -14.0% | −$41.00M | ||
| 2016 | $293.00M | +11.4% | +$30.00M | ||
| 2015 | $263.00M | -14.6% | −$45.00M | ||
| 2014 | $308.00M | +33.3% | +$77.00M | ||
| 2013 | $231.00M | +26.8% | +$48.80M | ||
| 2012 | $182.20M | +12.8% | +$20.70M | ||
| 2011 | $161.50M | -21.4% | −$43.90M | ||
| 2010 | $205.40M | +23.1% | +$38.50M | ||
| 2009 | $166.90M | -21.5% | −$45.80M | ||
| 2008 | $212.70M | -2.9% | −$6.40M | ||
| 2007 | $219.10M | +13.3% | +$25.68M | ||
| 2006 | $193.42M | -13.8% | −$30.85M | ||
| 2005 | $224.27M | +27.3% | +$48.15M | ||
| 2004 | $176.13M | +0.8% | +$1.48M | ||
| 2003 | $174.64M | +12.5% | +$19.45M | ||
| 2002 | $155.20M | +4.2% | +$6.21M | ||
| 2001 | $148.99M | +27.9% | +$32.54M | ||
| 2000 | $116.45M | -89.4% | −$984.55M | ||
| 1999 | $1.10B | +2618.5% | +$1.06B | ||
| 1998 | $40.50M | -13.5% | −$6.30M | ||
| 1997 | $46.80M | -33.5% | −$23.60M | ||
| 1996 | $70.40M | — | — |
- 2025$527.00M+24.0%
- 2024$425.00M+4.2%
- 2023$408.00M+1.0%
- 2022$404.00M+0.2%
- 2021$403.00M-3.6%
- 2020$418.00M+4.5%
- 2019$400.00M+4.4%
- 2018$383.00M+52.0%
- 2017$252.00M-14.0%
- 2016$293.00M+11.4%
- 2015$263.00M-14.6%
- 2014$308.00M+33.3%
- 2013$231.00M+26.8%
- 2012$182.20M+12.8%
- 2011$161.50M-21.4%
- 2010$205.40M+23.1%
- 2009$166.90M-21.5%
- 2008$212.70M-2.9%
- 2007$219.10M+13.3%
- 2006$193.42M-13.8%
- 2005$224.27M+27.3%
- 2004$176.13M+0.8%
- 2003$174.64M+12.5%
- 2002$155.20M+4.2%
- 2001$148.99M+27.9%
- 2000$116.45M-89.4%
- 1999$1.10B+2618.5%
- 1998$40.50M-13.5%
- 1997$46.80M-33.5%
- 1996$70.40M—
CapEx values are taken from Quest Diagnostics's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current CapEx (TTM) is $524.00M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Quest Diagnostics (DGX) most recent annual CapEx stands at $527.00M (2025) – grew 24.0% year-over-year.
Over 2020–2025 (5 years), Quest Diagnostics CapEx expanded at a +4.7% compound annual rate, sustaining 4 straight years of year-over-year growth.
Quest Diagnostics CapEx plunged from $1.10B in 1999 to $527.00M in 2025, a 52.1% drawdown.
Across the available history, CapEx reached its high of $1.10B in 1999 and its low of $40.50M in 1998.
Quest Diagnostics Capital Expenditures by Year
Quest Diagnostics Capital Expenditures 2025: $527.00M
Quest Diagnostics CapEx in 2025 was $527.00M, grew 24.0% from 2024.
Quest Diagnostics Capital Expenditures 2024: $425.00M
2024's CapEx for Quest Diagnostics came in at $425.00M, edged up 4.2% from 2023.
Quest Diagnostics Capital Expenditures 2023: $408.00M
Quest Diagnostics posted CapEx of $408.00M in 2023, edged up 1.0% from 2022.
Quest Diagnostics Capital Expenditures 2022: $404.00M
In 2022, Quest Diagnostics reported CapEx of $404.00M, edged up 0.2% from 2021.
Quest Diagnostics Capital Expenditures 2021: $403.00M
Quest Diagnostics CapEx in 2021 was $403.00M.
See more financial history for Quest Diagnostics (DGX).
Sector peers by CapEx
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $5.91B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $5.91B
- $4.83B
- $4.11B
- $3.62B
- $1.86B
- $1.21B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation